Protocol

Moxidectin in Onchocerciasis: Ongoing Clinical Trial Protocols 1

MDGH-MOX-3001: Safety and efficacy of annual or biannual doses of moxidectin or ivermectin for onchocerciasis​ (Target: approx. 1,000 participants)​.

MDGH-MOX-3001: Safety and efficacy of annual or biannual doses of moxidectin or ivermectin for onchocerciasis​ (Target: approx. 1,000 participants)​.